Symbols / BHST Stock $4.21 -0.94% BioHarvest Sciences Inc. Common Stock

Consumer Defensive • Packaged Foods • Canada • NGM
BHST (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Consumer Defensive
Industry Packaged Foods
CEO Mr. Ilan Sobel
Exch · Country NGM · Canada
Market Cap 95.43M
Enterprise Value 86.50M
Income -11.13M
Sales 34.51M
FCF (ttm) -10.78M
Book/sh 1.12
Cash/sh 1.02
Employees 89
Insider 10d —
IPO Jan 08, 2021
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E -49.53
PEG —
P/S 2.77
P/B 3.75
P/C —
EV/EBITDA -16.92
EV/Sales 2.51
Quick Ratio 3.29
Current Ratio 3.97
Debt/Eq 55.42
LT Debt/Eq —
EPS (ttm) -0.60
EPS next Y -0.09
EPS Growth —
Revenue Growth 24.60%
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-05-14
Earnings (prior) 2026-03-31
ROA -9.59%
ROE -83.17%
ROIC —
Gross Margin 59.34%
Oper. Margin -12.37%
Profit Margin -32.27%
Shs Outstand 22.67M
Shs Float 17.82M
Insider Own 16.60%
Instit Own 8.28%
Short Float 0.34%
Short Ratio 2.41
Short Interest 65.29K
52W High 12.80
vs 52W High -67.11%
52W Low 4.10
vs 52W Low 2.68%
Beta 1.40
Impl. Vol. —
Rel Volume 2.46
Avg Volume 22.89K
Volume 56.23K
Target (mean) $12.75
Tgt Median $13.00
Tgt Low $10.00
Tgt High $15.00
# Analysts 4
Recom Strong_buy
Prev Close $4.25
Price $4.21
Change -0.94%
About

BioHarvest Sciences Inc. operates as a biotechnology company in Israel and the United States. It operates through Nutraceuticals and Pharmaceuticals segments. The company develops botanical synthesis platform technology to produce plant cells with higher concentrations of active ingredients. It is involved in the research, development, manufacturing, marketing, and sale of science based health and wellness nutraceutical solutions that are manufactured and sold as dietary supplements and functional foods, as well as manufacturing, marketing, and sale of science-based health and cosmeceutical solutions. The company also provides contract development and manufacturing operation services. Further, it offers VINIA, a red grape cell dietary supplement containing the matrix of polyphenols contained in red wine. The company is based in Vancouver, Canada.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$12.75
Mean price target
2. Current target
$4.21
Latest analyst target
3. DCF / Fair value
$-8.56
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$4.21
Low
$10.00
High
$15.00
Mean
$12.75

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-02-19 init Roth Capital — → Buy $10
2025-04-08 reit HC Wainwright & Co. Buy → Buy $14
2024-12-18 init Maxim Group — → Buy $12
2024-12-11 reit HC Wainwright & Co. Buy → Buy $14
2024-12-06 init HC Wainwright & Co. — → Buy $14
News
RSS: Latest BHST news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-03-03 Levy (Yehesket Chezy) Director of Issuer — 0 — —
2025-09-19 Binder (Anne) Director of Issuer — 1,750 $6.50 $11,375
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
34.51
+37.00%
25.19
+98.77%
12.67
+130.48%
5.50
Operating Revenue
34.51
+37.00%
25.19
+98.77%
12.67
+130.48%
5.50
Cost Of Revenue
14.03
+24.77%
11.25
+59.77%
7.04
+64.50%
4.28
Reconciled Cost Of Revenue
12.85
+23.63%
10.39
+63.61%
6.35
+69.96%
3.74
Gross Profit
20.48
+46.87%
13.94
+147.51%
5.63
+362.10%
1.22
Operating Expense
26.05
+24.46%
20.93
+34.18%
15.60
+31.85%
11.83
Research And Development
5.31
+10.74%
4.80
+42.39%
3.37
+45.97%
2.31
Selling General And Administration
19.14
+30.49%
14.67
+21.47%
12.08
+29.13%
9.35
Selling And Marketing Expense
13.21
+42.63%
9.26
+44.81%
6.40
+48.68%
4.30
General And Administrative Expense
5.93
+9.71%
5.41
-4.81%
5.68
+12.48%
5.05
Salaries And Wages
4.96
+23.83%
4.00
+13.75%
3.52
+0.49%
3.50
Other Gand A
0.97
-30.56%
1.40
-34.24%
2.13
+41.48%
1.51
Other Operating Expenses
1.16
+8.35%
1.07
—
—
Total Expenses
40.08
+24.57%
32.18
+42.14%
22.64
+40.52%
16.11
Operating Income
-5.58
+20.23%
-6.99
+29.87%
-9.97
+6.09%
-10.61
Total Operating Income As Reported
-5.58
+20.23%
-6.99
+29.87%
-9.97
+6.09%
-10.61
EBITDA
-6.71
+2.95%
-6.92
+29.15%
-9.76
-6.98%
-9.12
Normalized EBITDA
-4.88
+24.11%
-6.43
+30.54%
-9.26
+7.25%
-9.99
Reconciled Depreciation
1.62
+29.82%
1.25
+48.93%
0.84
+17.98%
0.71
EBIT
-8.34
-2.07%
-8.17
+22.97%
-10.60
-7.78%
-9.84
Total Unusual Items
-1.83
-278.88%
-0.48
+3.40%
-0.50
-158.07%
0.86
Total Unusual Items Excluding Goodwill
-1.83
-278.88%
-0.48
+3.40%
-0.50
-158.07%
0.86
Net Income
-11.13
+13.77%
-12.91
-2.78%
-12.56
-11.82%
-11.24
Pretax Income
-11.06
+14.30%
-12.90
-2.71%
-12.56
-11.82%
-11.24
Net Non Operating Interest Income Expense
-3.65
+32.74%
-5.43
-158.96%
-2.10
-41.28%
-1.49
Interest Expense Non Operating
2.72
-42.53%
4.74
+141.49%
1.96
+40.24%
1.40
Net Interest Income
-3.65
+32.74%
-5.43
-158.96%
-2.10
-41.28%
-1.49
Interest Expense
2.72
-42.53%
4.74
+141.49%
1.96
+40.24%
1.40
Interest Income Non Operating
0.05
0.00
—
—
Interest Income
0.05
0.00
—
—
Other Income Expense
-1.83
-278.88%
-0.48
+3.40%
-0.50
-158.07%
0.86
Gain On Sale Of Security
-1.83
-278.88%
-0.48
+3.40%
-0.50
-158.07%
0.86
Tax Provision
0.08
+850.00%
0.01
0.00
—
Tax Rate For Calcs
0.00
+0.00%
0.00
0.00
0.00
Tax Effect Of Unusual Items
-0.38
-278.88%
-0.10
0.00
0.00
Net Income Including Noncontrolling Interests
-11.13
+13.77%
-12.91
-2.78%
-12.56
-11.82%
-11.24
Net Income From Continuing Operation Net Minority Interest
-11.13
+13.77%
-12.91
-2.78%
-12.56
-11.82%
-11.24
Net Income From Continuing And Discontinued Operation
-11.13
+13.77%
-12.91
-2.78%
-12.56
-11.82%
-11.24
Net Income Continuous Operations
-11.13
+13.77%
-12.91
-2.78%
-12.56
-11.82%
-11.24
Normalized Income
-9.69
+22.68%
-12.53
-3.87%
-12.06
+0.27%
-12.10
Net Income Common Stockholders
-11.13
+13.77%
-12.91
-2.78%
-12.56
-11.82%
-11.24
Diluted EPS
-0.60
+25.00%
-0.80
+13.98%
-0.93
-32.86%
-0.70
Basic EPS
-0.60
+25.00%
-0.80
+13.98%
-0.93
-32.86%
-0.70
Basic Average Shares
18.41
+13.69%
16.19
+19.66%
13.53
+3.67%
13.05
Diluted Average Shares
18.41
+13.69%
16.19
+19.66%
13.53
+3.67%
13.05
Diluted NI Availto Com Stockholders
-11.13
+13.77%
-12.91
-2.78%
-12.56
-11.82%
-11.24
Depreciation Amortization Depletion Income Statement
0.44
+10.78%
0.40
+159.09%
0.15
-9.94%
0.17
Depreciation And Amortization In Income Statement
0.44
+10.78%
0.40
+159.09%
0.15
-9.94%
0.17
Depreciation Income Statement
—
—
0.16
-8.77%
0.17
Rent And Landing Fees
—
0.03
+3.85%
0.03
-33.33%
0.04
Rent Expense Supplemental
—
0.03
+3.85%
0.03
-33.33%
0.04
Total Other Finance Cost
0.98
+41.73%
0.69
+411.03%
0.14
+58.14%
0.09
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
47.66
+90.65%
25.00
+66.65%
15.00
+59.71%
9.39
Current Assets
30.50
+288.24%
7.86
-13.21%
9.05
+109.44%
4.32
Cash Cash Equivalents And Short Term Investments
23.02
+863.39%
2.39
-55.37%
5.36
+208.47%
1.74
Cash And Cash Equivalents
23.02
+863.39%
2.39
-55.37%
5.36
+208.47%
1.74
Receivables
2.24
+67.14%
1.34
+38.64%
0.97
+34.07%
0.72
Accounts Receivable
1.98
+77.51%
1.12
+38.12%
0.81
+48.26%
0.55
Other Receivables
0.26
+15.93%
0.23
+41.25%
0.16
-9.60%
0.18
Inventory
4.56
+24.73%
3.65
+48.22%
2.47
+78.96%
1.38
Raw Materials
0.84
+50.63%
0.56
+31.37%
0.42
+194.44%
0.14
Work In Process
2.51
+9.79%
2.29
+40.65%
1.63
+37.45%
1.18
Finished Goods
1.21
+49.08%
0.81
+94.95%
0.42
+715.69%
0.05
Prepaid Assets
0.67
+43.50%
0.47
+78.33%
0.26
-45.88%
0.49
Total Non Current Assets
17.16
+0.12%
17.14
+188.15%
5.95
+17.33%
5.07
Net PPE
16.73
-0.25%
16.77
+190.66%
5.77
+17.58%
4.91
Gross PPE
18.91
-0.05%
18.92
+153.39%
7.47
+0.85%
7.40
Accumulated Depreciation
-2.18
-1.54%
-2.15
-26.59%
-1.70
+32.05%
-2.50
Properties
0.00
0.00
0.00
0.00
Buildings And Improvements
17.63
+2.25%
17.24
+188.99%
5.96
+121.99%
2.69
Machinery Furniture Equipment
0.21
-45.80%
0.39
+44.49%
0.27
+31.40%
0.21
Other Properties
0.83
-6.74%
0.89
+7.23%
0.83
-78.93%
3.94
Leases
0.24
-39.25%
0.40
+0.00%
0.40
-29.95%
0.57
Other Non Current Assets
0.43
+16.71%
0.37
+107.26%
0.18
+9.82%
0.16
Total Liabilities Net Minority Interest
22.22
-6.14%
23.67
-20.71%
29.86
+94.85%
15.32
Current Liabilities
7.68
-46.11%
14.26
-46.13%
26.47
+129.77%
11.52
Payables And Accrued Expenses
3.55
-23.10%
4.62
+77.62%
2.60
+69.01%
1.54
Payables
3.17
-24.93%
4.22
+96.87%
2.14
+55.74%
1.38
Accounts Payable
2.63
-25.48%
3.52
+98.26%
1.78
+66.64%
1.07
Other Payable
0.54
-22.19%
0.69
+90.14%
0.36
+18.12%
0.31
Current Accrued Expenses
0.39
-3.74%
0.40
-12.45%
0.46
+180.98%
0.16
Employee Benefits
—
—
0.00
-100.00%
0.12
Pensionand Other Post Retirement Benefit Plans Current
1.53
+23.82%
1.23
+18.20%
1.04
+49.57%
0.70
Current Debt And Capital Lease Obligation
1.55
-66.77%
4.68
-77.64%
20.91
+135.32%
8.89
Current Debt
0.15
-96.18%
3.90
-80.98%
20.53
+140.18%
8.55
Other Current Borrowings
0.15
-96.18%
3.90
-80.98%
20.53
+140.18%
8.55
Current Capital Lease Obligation
1.41
+81.99%
0.77
+102.09%
0.38
+12.68%
0.34
Current Deferred Liabilities
0.49
-62.24%
1.30
+55.86%
0.84
+112.18%
0.39
Current Deferred Revenue
0.49
-62.24%
1.30
+55.86%
0.84
+112.18%
0.39
Other Current Liabilities
0.45
-60.35%
1.14
+116.73%
0.53
—
Total Non Current Liabilities Net Minority Interest
14.53
+54.39%
9.41
+177.83%
3.39
-10.91%
3.80
Long Term Debt And Capital Lease Obligation
12.55
+37.29%
9.14
+541.47%
1.43
-14.67%
1.67
Long Term Debt
2.42
—
—
—
Long Term Capital Lease Obligation
10.13
+10.82%
9.14
+541.47%
1.43
-14.67%
1.67
Tradeand Other Payables Non Current
—
—
—
—
Non Current Deferred Liabilities
—
—
—
2.01
Non Current Deferred Revenue
—
—
—
2.01
Other Non Current Liabilities
1.98
+629.04%
0.27
-86.14%
1.96
-2.34%
2.01
Stockholders Equity
25.45
+1813.38%
1.33
+108.95%
-14.85
-150.51%
-5.93
Common Stock Equity
25.45
+1813.38%
1.33
+108.95%
-14.85
-150.51%
-5.93
Capital Stock
133.00
+36.07%
97.75
+42.38%
68.65
+5.60%
65.01
Common Stock
133.00
+36.07%
97.75
+42.38%
68.65
+5.60%
65.01
Share Issued
22.67
+30.81%
17.33
+26.69%
13.68
+3.90%
13.16
Ordinary Shares Number
22.67
+30.81%
17.33
+26.69%
13.68
+3.90%
13.16
Retained Earnings
-107.55
-11.55%
-96.42
-15.46%
-83.50
-17.71%
-70.94
Total Equity Gross Minority Interest
25.45
+1813.38%
1.33
+108.95%
-14.85
-150.51%
-5.93
Total Capitalization
27.87
+1995.34%
1.33
+108.95%
-14.85
-150.51%
-5.93
Working Capital
22.82
+456.39%
-6.40
+63.24%
-17.41
-141.98%
-7.20
Invested Capital
28.02
+435.19%
5.24
-7.83%
5.68
+116.79%
2.62
Total Debt
14.10
+2.07%
13.82
-38.15%
22.34
+111.59%
10.56
Net Debt
—
1.51
-90.02%
15.18
+122.78%
6.81
Capital Lease Obligations
11.54
+16.36%
9.91
+448.59%
1.81
-10.05%
2.01
Net Tangible Assets
25.45
+1813.38%
1.33
+108.95%
-14.85
-150.51%
-5.93
Tangible Book Value
25.45
+1813.38%
1.33
+108.95%
-14.85
-150.51%
-5.93
Current Provisions
0.10
-91.82%
1.28
+135.60%
0.55
—
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-7.23
-8.11%
-6.68
+21.57%
-8.52
+7.78%
-9.24
Cash Flow From Continuing Operating Activities
-7.23
-8.11%
-6.68
+21.57%
-8.52
+7.78%
-9.24
Net Income From Continuing Operations
-11.13
+13.77%
-12.91
-2.78%
-12.56
-11.82%
-11.24
Depreciation Amortization Depletion
1.62
+29.82%
1.25
+48.93%
0.84
+17.98%
0.71
Depreciation
—
1.25
+48.93%
0.84
—
Depreciation And Amortization
1.62
+29.82%
1.25
+48.93%
0.84
+17.98%
0.71
Other Non Cash Items
3.63
+255.53%
1.02
+17.90%
0.87
+627.73%
0.12
Stock Based Compensation
0.60
-0.67%
0.60
+6.75%
0.56
-58.36%
1.35
Operating Gains Losses
—
3.91
+152.32%
1.55
+493.87%
0.26
Gain Loss On Investment Securities
—
3.91
+152.32%
1.55
+493.87%
0.26
Change In Working Capital
-1.94
-249.91%
-0.56
-173.51%
0.76
+345.13%
-0.31
Change In Receivables
-1.10
-86.03%
-0.59
-2600.00%
-0.02
+96.26%
-0.59
Changes In Account Receivables
-0.86
-180.84%
-0.31
-17.56%
-0.26
-64.78%
-0.16
Change In Inventory
-0.90
+23.97%
-1.19
-9.28%
-1.09
-141.78%
-0.45
Change In Payables And Accrued Expense
0.48
-53.65%
1.04
-31.17%
1.51
+106.99%
0.73
Change In Other Working Capital
-0.41
-320.74%
0.19
-46.89%
0.35
—
Investing Cash Flow
-2.37
+21.87%
-3.03
-105.36%
-1.47
-17.36%
-1.26
Cash Flow From Continuing Investing Activities
-2.37
+21.87%
-3.03
-105.36%
-1.47
-17.36%
-1.26
Net PPE Purchase And Sale
-2.35
+16.93%
-2.83
-92.33%
-1.47
-17.36%
-1.26
Purchase Of PPE
-2.35
+16.93%
-2.83
-92.33%
-1.47
-17.36%
-1.26
Capital Expenditure
-2.35
+16.93%
-2.83
-92.33%
-1.47
-17.36%
-1.26
Net Other Investing Changes
-0.01
+94.79%
-0.19
—
—
Financing Cash Flow
30.19
+345.24%
6.78
-49.99%
13.56
+66.58%
8.14
Cash Flow From Continuing Financing Activities
30.19
+345.24%
6.78
-49.99%
13.56
+66.58%
8.14
Net Issuance Payments Of Debt
5.25
+157.00%
2.04
-84.48%
13.15
+80.20%
7.30
Issuance Of Debt
12.40
+262.95%
3.42
-74.72%
13.52
+76.51%
7.66
Repayment Of Debt
-7.15
-420.29%
-1.38
-277.75%
-0.36
-1.39%
-0.36
Long Term Debt Issuance
12.40
+262.95%
3.42
-74.72%
13.52
+76.51%
7.66
Long Term Debt Payments
-7.15
-420.29%
-1.38
-277.75%
-0.36
-1.39%
-0.36
Net Long Term Debt Issuance
5.25
+157.00%
2.04
+660.99%
-0.36
-104.99%
7.30
Short Term Debt Issuance
—
3.31
-75.48%
13.52
—
Short Term Debt Payments
—
—
—
—
Net Short Term Debt Issuance
—
3.31
-75.48%
13.52
—
Net Common Stock Issuance
18.26
+321.76%
4.33
0.00
0.00
Proceeds From Stock Option Exercised
6.84
+1575.49%
0.41
+1.24%
0.40
-54.05%
0.88
Net Other Financing Charges
-0.16
—
—
-0.04
Changes In Cash
20.60
+802.70%
-2.93
-182.33%
3.56
+250.91%
-2.36
Effect Of Exchange Rate Changes
0.04
+214.71%
-0.03
-157.63%
0.06
+368.18%
-0.02
Beginning Cash Position
2.39
-55.37%
5.36
+208.47%
1.74
-57.83%
4.12
End Cash Position
23.02
+863.39%
2.39
-55.37%
5.36
+208.47%
1.74
Free Cash Flow
-9.58
-0.65%
-9.52
+4.77%
-10.00
+4.77%
-10.50
Common Stock Issuance
18.26
+321.76%
4.33
0.00
0.00
Interest Paid CFO
—
0.00
+100.00%
-0.53
-277.30%
-0.14
Issuance Of Capital Stock
18.26
+321.76%
4.33
0.00
0.00
SEC Filings

No SEC filings found for this symbol (may be non-US or ticker not in SEC index).

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category